Search research articles
Contact Us
Filters
Showing results (581-590 of 596) with videos related to
Page
of 60
Sort By:
Pediatrics
|
May 10, 2020
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Cynthia Sharpe, Gail E Reiner, Suzanne L Davis, et al.
Ecology Letters
|
May 10, 2023
Herbaceous vegetation responses to experimental fire in savannas and forests depend on biome and climate
Zachary J Gold, Adam F A Pellegrini, Tyler K Refsland, et al.
JCO Precision Oncology
|
February 14, 2024
Sunitinib in Patients With Breast Cancer With <i>FGFR1</i> or <i>FGFR2</i> Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
Carmen J Calfa, Michael Rothe, Pam K Mangat, et al.
The Journal of Clinical Investigation
|
March 27, 2014
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation
Frann Antignano, Kyle Burrows, Michael R Hughes, et al.
Biogeochemistry
|
August 21, 2019
Watershed 'Chemical Cocktails': Forming Novel Elemental Combinations in Anthropocene Fresh Waters
Sujay S Kaushal, Arthur J Gold, Susana Bernal, et al.
Cell Reports
|
January 13, 2021
Mechanical Stiffness Controls Dendritic Cell Metabolism and Function
Mainak Chakraborty, Kevin Chu, Annie Shrestha, et al.
Cell Metabolism
|
December 8, 2021
Coenzyme A fuels T cell anti-tumor immunity
Michael St Paul, Samuel D Saibil, SeongJun Han, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
JCO Precision Oncology
|
December 1, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Nitin Rohatgi, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 596) with videos related to
Sort By:
Page
of 60
Pediatrics
|
May 10, 2020
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Cynthia Sharpe, Gail E Reiner, Suzanne L Davis, et al.
Ecology Letters
|
May 10, 2023
Herbaceous vegetation responses to experimental fire in savannas and forests depend on biome and climate
Zachary J Gold, Adam F A Pellegrini, Tyler K Refsland, et al.
JCO Precision Oncology
|
February 14, 2024
Sunitinib in Patients With Breast Cancer With <i>FGFR1</i> or <i>FGFR2</i> Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
Carmen J Calfa, Michael Rothe, Pam K Mangat, et al.
The Journal of Clinical Investigation
|
March 27, 2014
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation
Frann Antignano, Kyle Burrows, Michael R Hughes, et al.
Biogeochemistry
|
August 21, 2019
Watershed 'Chemical Cocktails': Forming Novel Elemental Combinations in Anthropocene Fresh Waters
Sujay S Kaushal, Arthur J Gold, Susana Bernal, et al.
Cell Reports
|
January 13, 2021
Mechanical Stiffness Controls Dendritic Cell Metabolism and Function
Mainak Chakraborty, Kevin Chu, Annie Shrestha, et al.
Cell Metabolism
|
December 8, 2021
Coenzyme A fuels T cell anti-tumor immunity
Michael St Paul, Samuel D Saibil, SeongJun Han, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
JCO Precision Oncology
|
December 1, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Nitin Rohatgi, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Page
of 60